1. Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models;Bergstrand;AAPS. J.,2011
2. Pathology of nonalcoholic steatohepatitis;Brunt;Hepatol. Res.,2005
3. Stability and performance of a population pharmacokinetic model;Ette;J. Clin. Pharmacol.,1997
4. FDA 2024: FDA Approves First Treatment for Patients with Liver Scarring Due to Fatty Liver Disease. 2024; Available from: https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-patients-liver-scarring-due-fatty-liver-disease.
5. Challenges and opportunities in NASH drug development;Harrison;Nat. Med.,2023